Veru Announces Publication Of Data From Three Cancer Studies As Part Of The Upcoming American Society Of Clinical Oncology Annual Meeting | Latest News RSS feed

Veru Announces Publication Of Data From Three Cancer Studies As Part Of The Upcoming American Society Of Clinical Oncology Annual Meeting - Latest News


Veru Announces Publication of Data from Three Cancer Studies as Part of the Upcoming American Society of Clinical Oncology Annual Meeting

MIAMI, May 17, 2018 (GLOBE NEWSWIRE) -- Veru Inc. (VERU), a urology and oncology biopharmaceutical company, today announced the publication of data from preclinical studies of VERU-111, a novel oral a... read more

Selecta Biosciences Announces Second Quarter 2018 Financial Results and Provides Corporate Update

Expanded three-month ... with pancreatic cancer, and is further exploring additional studies in other cancers. Preclinical Work Continues in Gene Therapy: Previously presented data from the 2017 annua... read more

Veru Healthcare : Presents Results from Phase 4 Clinical Study of PREBOOST for Management of Premature Ejaculation

Veru Healthcare (NASDAQ:FHCO) today announced positive results from a Phase 4 clinical study ... for inclusion in the American Urological Association’s (AUA) Annual Meeting Press Conference, held this ... read more

Looking for another news?


Curis, Inc. (CRIS)

On November 7, 2017, Curis, Inc. announced its financial results for the three ... Cancer (SITC) Meeting. In our CUDC-907 program, we expect to present data supporting its clinical benefit in patients ... read more


VERU Jun 2018 2.500 call

Veru Inc. (VERU), a urology and oncology biopharmaceutical company, today announced the publication of data from preclinical studies ... the three cancers, were published as part of the upcoming 2018 ... read more

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

New data analyses in... BerGenBio ASA (OSE: BGBIO) announces ... from a number of studies across the company's oncology product and pipeline portfolio will be presented at the 54th Annual Meeting of t... read more

Veru Reports Fiscal 2018 Second-Quarter Financial Results

-- Promising Oncology Drug Data to be Presented at Upcoming American Urological ... BE Clinical Studies Results Anticipated for Drugs in ... -- Promising Oncology Drug Data to be Presented at Upcoming ... read more

Curis Reports Third Quarter 2017 Financial Results

In our CUDC-907 program, we expect to present data supporting its clinical benefit in patients with MYC-altered DLBCL at the upcoming American Society ... Cancer (SITC) 32 nd Annual Meeting (Nov. 8-12 ... read more

Technology - Spokane, North Idaho News & Weather KHQ.com

Corporate Colocation with over twelve years of providing data center service in Los ... GoverMedia Plus Canada Corp. Announces Partnership with Latvian Chamber of Commerce & Leading Russian Technology ... read more

Veru Announces Publication of Data from Three Cancer Studies as Part of the Upcoming American Society of Clinical Oncology Annual Meeting

--Data of Company’s Proprietary Drug, Oral VERU-111, Shows Efficacy in Multiple Cancer Models: Human Taxane-Resistant Triple Negative Breast Cancer, Pancreatic Cancer and Ovarian Cancer-- MIAMI, May 1... read more

Fil de presse

As part of the Novartis environmental ... Novartis will present data from across its oncology portfolio at the upcoming 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO), being h... read more

Oncolytics Biotech® to Present REOLYSIN® Safety Data in combination with chemotherapy at ESMO 2017 Congress

Announces end-of-phase 2 meeting with ... safety and tolerability data and the mechanism of REOLYSIN ®, also known as pelareorep ®, have been selected for poster presentation (display) at the European ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us